This site is intended for UK healthcare professionals
Medscape UK Univadis Logo
Medscape UK Univadis Logo
News

GMC Contests Legal Action Over Medical Professionals

The General Medical Council (GMC) has dismissed a decision by the British Medical Association' (BMA) to take legal action over the use of the term 'medical professional' as "not even arguable".

The GMC has used the term 'medical professionals' to describe all its future registrants, regardless of whether they are doctors or associates. The BMA recently launched a judicial review claim against the GMC over its use of this label, which the association said should only ever be used to refer to qualified doctors.

It took the step to stop the "dangerous blurring of the lines" between skilled and trained doctors and the medical associate professions (MAPs), it claimed that action was needed before the "uncontrolled experiment" of the use of MAPs "leads to more unintended patient harm". At the BMA's annual representative meeting, council chair Professor Philip Banfield said the Association would not stand for the government and NHS leadership "eroding" the profession any further.

But in a statement on Tuesday, the GMC said: "We have responded to the BMA today, strongly rejecting the basis on which they have threatened to bring legal proceedings. We believe the grounds for the threatened judicial review are not even arguable."

Regulation Needed But Not by GMC

The legal move comes in the wake of recent legislation which will see the GMC take responsibility for regulating physician associates (PAs) and anaesthesia associates (AAs) from December 2024.

The BMA has argued that both professions – who complete a 2-year course rather than a 5-year medical degree – need regulating, but that the GMC is not the right organisation to do it.

Alongside the BMA, Anaesthetists United, an independent group of grassroots anaesthetists, is planning separate but complementary legal action, which relates to the lack of any national regulation of scope of practice for PAs and AAs.

In a statement on Tuesday, the GMC said: "We have extensively and formally consulted with the BMA over several years in relation to the core standards to be set for PAs and AAs." The regulator pointed out that since 2021 it had made the BMA and others aware of its intention to apply its core professional standards to doctors, PAs, and AAs, "and received no objections from them at all".

Earlier this year, the Royal College of General Practitioners (RCGP) UK governing Council meeting raised concerns that regulation by the GMC of PAs risked confusing patients in distinguishing between doctors and PAs. Subsequently, the College said that another regulatory body would be a more appropriate regulator. 

Last month, the RCGP called for a halt to recruitment of physician associates in general practice. It came after a consultation with more than 5000 GPs. In March this year, members and fellows of the Royal College of Physicians (RCP) voted overwhelmingly to limit the pace and scale of the rollout of PAs.

Doctors Are The Medical Profession

MAPs have been under increased scrutiny following the case of Emily Chesterton, who was twice misdiagnosed by a PA before eventually dying of a blood clot in 2022. 

"PAs are not doctors, and we have seen the tragic consequences of what happens when this is not made clear to patients," Banfield said. "Everyone has the right to know who the healthcare professional they are seeing is and what they are qualified to do – and crucially, not to do."

Emphasising that doctors are "the medical profession", he said that describing any other staff as medical professionals risked undermining the skills of trained doctors and confusing patients.

However, the GMC stated that the term 'medical professionals' "is not a protected title, and our use of it is both lawful and appropriate".

It said: "We have made it very clear we will recognise and regulate doctors, PAs, and AAs as three distinct professions. To register with us, PAs and AAs will also need to show that they have the knowledge, skills, and experience to treat patients safely, and that there are no outstanding concerns about their fitness to practise."

YOU MAY ALSO LIKE

The new Labour Government faces a monumental task as they promise to initiate discussions on day one, following 11 strikes in 20 months.
A panel of dermatologists shared their views on personalising management for this population at an elevated risk for poor outcomes.
COVID vaccination was linked to 70% reduced mortality and 45% reduced hospitalisations in England.
Patients at a high risk for HIV infection who received preexposure prophylactic injections with lenacapavir had 100% efficacy in a phase 3 clinical trial.
Two batches of itraconazole oral solution have been recalled by a manufacturer after the discovery of suspended particles or clusters of crystals.
Specific antipsychotics prescribed in high doses were linked to an increased risk for pneumonia in patients with schizophrenia, new research showed.
Adults aged 35 and over who continue smoking lose up to 9 years of life expectancy, but quitting can prevent most of this loss.
Individuals with high levels of xylitol in their blood are at a 57% increased risk of severe cardiovascular events, according to new research.
A ketogenic diet and regular physical exercise appear to be effective first-line treatments for narcolepsy, new research suggested.
A review of the Global Initiative for Asthma’s 2024 strategy for the management and prevention of asthma
The dissolution of the government and call for elections have delayed, and perhaps thwarted, several anticipated health initiatives.
Patients on the drugs for weight management are more than seven times as likely to develop the condition as those on other weight-loss meds.
A lack of scientific evidence on safety and efficacy appeared to be the major driver of discomfort with these therapies.
Older adults presenting with new-onset anxiety might be showing early Parkinson's signs.
Includes chickenpox treatment recommendations for immunosuppressed individuals and pregnant women
The trial found that a higher-exposure dupilumab regimen improved key secondary endpoints in children.
Knowing if a patient has served in the armed forces can help GPs tailor care to their needs.
Interim results of the INSPIRE trial showed improved limb function, mobility, pain, and fatigue in patients with SORD deficiency and sustained sorbitol reduction vs placebo.
Women are recommended to discontinue the weight loss/type 2 diabetes drugs months before conceiving, but that places them in a rebound mode of weight gain and reversal of glycemic benefits.